Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province, Hangzhou, China; Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province, Hangzhou, China.
Int J Med Microbiol. 2020 Dec;310(8):151464. doi: 10.1016/j.ijmm.2020.151464. Epub 2020 Oct 24.
Acinetobacter baumannii has emerged as a problematic hospital pathogen and tigecycline is among the few remaining antibiotics retaining activity against multidrug-resistant A. baumannii. This study was aimed to elucidate the tigecycline resistance mechanisms in 28 unique clinical A. baumannii strains from nine provinces in China.
Whole genome sequences were obtained via Illumina HiSeq sequencing and regulatory genes of efflux pumps were analyzed. Minimal inhibitory concentrations (MICs) were determined by agar/microbroth dilution according to the guidelines recommended by Clinical and Laboratory Standards Institute (CLSI). Tigecycline susceptibility data was interpreted using breakpoints for Enterobacterales recommended by EUCAST v8.1.
The majority of isolates belonged to the international clonal lineage IC2 (n = 27, 96.4%). Four isolates were considered tigecycline-intermediate (MIC = 2 mg/L), twenty-four isolates were tigecycline-resistant. The insertion of ISAba1 in adeS was found in six isolates and was the most prevalent insertion element (IS). In four isolates we observed an insertion of ISAba1 in adeN, and two of them had IS26 insertions. Two mutations in adeN (deletion and premature stop codon) were observed only in the MIC = 4 mg/L isolates. Other mutations in adeRS (amino acid insertion/substitutions and premature stop codons) were only detected in the MIC ≥ 8 group. The novel substitutions E219 K in adeR and A130 T in adeS were observed in five and four isolates respectively, suggesting a mutational hotspot.
This study demonstrates that changes in transcription regulators were important mechanisms in tigecycline resistance in A. baumannii. Also, we identified several chromosomal hotspots that can be used for prediction of tigecycline resistance.
鲍曼不动杆菌已成为一种棘手的医院病原体,而替加环素是少数对多药耐药鲍曼不动杆菌仍具有活性的抗生素之一。本研究旨在阐明中国 9 个省的 28 株独特临床鲍曼不动杆菌菌株对替加环素的耐药机制。
通过 Illumina HiSeq 测序获得全基因组序列,并分析外排泵调节基因。根据临床和实验室标准协会(CLSI)推荐的指南,通过琼脂/微量肉汤稀释法测定最小抑菌浓度(MIC)。根据 EUCAST v8.1 推荐的肠杆菌科药敏折点解释替加环素药敏数据。
大多数分离株属于国际克隆谱系 IC2(n = 27,96.4%)。4 株被认为是替加环素中介(MIC = 2 mg/L),24 株是替加环素耐药。在 6 株菌中发现 adeS 中的 ISAba1 插入,这是最常见的插入元件(IS)。在 4 株菌中观察到 adeN 中的 ISAba1 插入,其中 2 株菌有 IS26 插入。仅在 MIC = 4 mg/L 分离株中观察到 adeN 中的 2 个突变(缺失和提前终止密码子)。adeRS(氨基酸插入/替换和提前终止密码子)中的其他突变仅在 MIC≥8 组中检测到。adeR 中的 E219 K 和 adeS 中的 A130 T 这两种新的替换突变分别在 5 株和 4 株菌中观察到,提示存在突变热点。
本研究表明,转录调节因子的变化是鲍曼不动杆菌对替加环素耐药的重要机制。此外,我们还鉴定了几个染色体热点,可用于预测替加环素耐药性。